



Supplementary Table 1 Demographic characteristics and sNfL in the healthy control 
group 
 
  Baseline Follow-up 
 n = 59 n = 30 
Female % (n) 78 (47) 83 (25) 
Age, mean years (SD, range) 39.9 (11.8, 22-71) 41.2 (12.5, 26-73) 
Serum Neurofilament Light levels, mean pgmL (SD, range) 7.0 (3.8, 2.2-21.6) 7.8 (3.7, 3.0-16.2) 
SD, standard deviation 
 
Sensitivity analysis 
To explore the effects of centre in our rLMM models we added center as a random effect term 
(Supplementary Table 2). In addition, we also used the same set-up with centre while restricting 
the sample to RRMS subjects only (Supplementary Table 3). 
 
Supplementary Table 2 Robust linear mixed models predicting sNfL with global 
disconnectome and lesion volume including centre as random effect term 
  GD T2LV 
Predictors Estimates CI t p Estimates CI t p 
(Intercept) -0.79 -1.87 – 0.29 -1.44 0.151 -0.51 -1.19 – 0.16 -1.48 0.138 
sNfL 0.03 0.01 – 0.05 2.94 0.003 -0.00 -0.02 – 0.01 -0.76 0.450 
Timepoint -0.00 -0.01 – 0.00 -0.88 0.377 0.02 0.01 – 0.02 7.45 <0.001 
Age 0.26 0.14 – 0.37 4.36 <0.001 0.20 0.13 – 0.27 5.43 <0.001 
Sex 
[Female] 
0.07 -0.18 – 0.32 0.58 0.560 0.08 -0.08 – 0.23 0.96 0.339 
diagnosis 
[PMS] 
0.72 -0.27 – 1.70 1.42 0.155 0.22 -0.40 – 0.84 0.69 0.492 
diagnosis 
[RRMS] 
0.67 -0.31 – 1.66 1.34 0.180 0.24 -0.38 – 0.86 0.75 0.453 
treatment 
[Effective] 








-0.01 -0.03 – -0.00 -2.31 0.021 0.01 -0.00 – 0.01 1.92 0.055 
Random Effects 
σ2 0.00 0.00 
τ00 0.89 ID 0.35 ID 
 
0.19 center 0.07 center 
ICC 1.00 1.00 
N 296 ID 296 ID 
 







0.070 / 0.998 0.090 / 0.999 
 
Supplementary Table 3 Robust linear mixed models predicting sNfL with global 
disconnectome and lesion volume including centre as random effect term for RRMS 
subjects only 
  GD T2LV 
Predictors Estimates CI t p Estimates CI t p 
(Intercept) -0.14 -0.64 – 0.37 -0.53 0.595 -0.30 -0.59 – -0.00 -1.98 0.048 
sNfL 0.03 0.01 – 0.06 2.66 0.008 0.00 -0.02 – 0.02 0.03 0.976 
Timepoint -0.00 -0.01 – 0.01 -0.40 0.692 0.02 0.01 – 0.03 6.09 <0.001 
Age 0.17 0.04 – 0.31 2.62 0.009 0.12 0.04 – 0.20 2.98 0.003 
Sex [Female] 0.09 -0.20 – 0.39 0.62 0.535 0.12 -0.06 – 0.29 1.27 0.204 
treatment 
[Effective] 
0.03 -0.01 – 0.06 1.43 0.152 -0.00 -0.02 – 0.02 -0.10 0.923 
treatment 
[Highly-effective] 
0.05 0.01 – 0.08 2.32 0.021 0.03 0.01 – 0.05 2.50 0.012 
sNfL * Timepoint -0.02 -0.03 – -0.00 -2.20 0.028 0.00 -0.01 – 0.02 0.55 0.580 
Random Effects 
σ2 0.00 0.00 
τ00 0.99 ID 0.35 ID 
 
0.18 center 0.06 center 
ICC 1.00 1.00 
N 243 ID 243 ID 
 
4 center 4 center 
 
Observations 412 411 
Marginal R2 / 
Conditional R2 
0.027 / 0.998 0.039 / 0.998 
 
Comparing statistical output 
We also performed comparing analyses comparing the output from more regular linear mixed 
models (LMM) with the robust linear mixed models that we performed as our main analysis. 
For global disconnectome (GD) see Supplementary Table 4, and for T2 lesion volume see 
Supplementary Table 5. 
 
Supplementary Table 4 Overview of the model performance of linear mixed models 
compared with robust linear mixed models for global disconnectome. 
 Linear mixed models Robust linear mixed models 
  sNfL sNfL 
Predictors Estimates CI Statistic p Estimates CI Statistic p 
(Intercept) -0.27 -1.25 – 0.72 -0.53 0.597 -0.29 
-
0.72 – 0.13 -1.34 0.179 




0.08 – 0.10 0.25 0.801 -0.01 
-
0.06 – 0.03 -0.61 0.542 
Timepoint 0.00 -0.09 – 0.09 0.06 0.950 0.01 
-
0.04 – 0.05 0.27 0.790 




0.11 – 0.39 1.09 0.276 0.08 
-




0.39 – 1.68 1.22 0.223 0.37 
-




0.76 – 1.21 0.44 0.658 0.13 
-




0.32 – 0.13 -0.81 0.416 -0.10 
-0.21 – -




-0.25 -0.47 – -0.03 -2.21 0.027 -0.12 
-0.23 – -
0.02 -2.34 0.019 
Random Effects 
σ2 0.23    0.05    
τ00 0.80 ID    0.13 ID    
ICC 0.78    0.71    
N 296 ID       296 ID       






   0.295 / 
0.799 




Supplementary Table 5 Overview of the model performance of linear mixed models 
compared with robust linear mixed models for T2 lesion volume. 
 
 Linear mixed models Robust linear mixed models 
  sNfL sNfL 
Predictors Estimates CI Statistic p Estimates CI Statistic p 
(Intercept) -0.43 -1.40 – 0.55 -0.85 0.393 -0.35 
-
0.77 – 0.07 -1.62 0.106 




0.08 – 0.10 0.20 0.842 -0.03 
-
0.07 – 0.02 -1.27 0.205 
Timepoint -0.01 -0.10 – 0.09 -0.17 0.867 0.01 
-
0.04 – 0.05 0.22 0.823 




0.09 – 0.40 1.22 0.224 0.08 
-




0.20 – 1.86 1.58 0.114 0.43 
-




0.63 – 1.33 0.70 0.485 0.17 
-




0.29 – 0.16 -0.56 0.576 -0.09 
-




-0.21 -0.43 – 0.02 -1.81 0.071 -0.11 
-0.21 – -
0.01 -2.08 0.037 
Random Effects 
σ2 0.24    0.05    
τ00 0.79 ID    0.13 ID    
ICC 0.77    0.71    
N 296 ID 296 ID 








Outlier detection for sNfL scores was performed following Tukey’s fence method, where a 
score is considered an outlier if the value is either below the first quartile - 1.5 * interquartile 
range (IQR) or above the third quartile + 1.5* IQR. However, removal of sNfL outliers did 
not affect the overall results, as described in Supplementary Table 6. 
 
 
Supplementary Table 6 Robust linear mixed models predicting sNfL with global 
disconnectome and lesion volume after removing sNfL outliers 
  GD T2LV 
Predictors Estimates CI t p Estimates CI t p 
(Intercept) -1.22 -2.22 – -0.21 -2.38 0.017 -0.75 -1.36 – -0.13 -2.39 0.017 
sNfL 0.02 0.00 – 0.04 2.19 0.028 -0.00 -0.01 – 0.01 -0.29 0.770 
Timepoint -0.00 -0.01 – 0.01 -0.49 0.622 0.02 0.01 – 0.02 7.03 2.0x10-12 
Age 0.20 0.06 – 0.34 2.76 0.006 0.13 0.04 – 0.22 2.99 0.003 
Sex [Female] 0.14 -0.12 – 0.40 1.06 0.290 0.13 -0.03 – 0.29 1.58 0.113 
Diagnosis [PMS] 1.73 0.67 – 2.80 3.19 0.001 1.17 0.52 – 1.82 3.54 4.1x10-4 
Diagnosis 
[RRMS] 
0.96 -0.05 – 1.96 1.87 0.061 0.35 -0.26 – 0.97 1.14 0.256 
Treatment 
[Effective] 
0.01 -0.02 – 0.04 0.50 0.616 -0.01 -0.02 – 0.01 -0.90 0.369 
Treatment 
[Highly-effective]                                    
0.01 -0.02 – 0.04 0.66 0.507 -0.00 -0.02 – 0.01 -0.17 0.869 
sNfL * Timepoint -0.01 -0.02 – 0.00 -1.19 0.233 0.00 -0.00 – 0.01 1.74 0.082 
Random Effects 
σ2 0.00 0.00 
τ00 0.97 ID 0.36 ID 
ICC 1.00 1.00 
N 287 ID 287 ID 
Observations 484 484 
Marginal R2 0.169 0.294 
 
Outliers identified: 23 from 512 observations across both timepoint 
Proportion (%) of outliers: 4.49 
Mean of the outliers: 28.74 
Mean sNfL without removing outliers: 8.80 
Mean sNfL after removing outliers: 7.86 
 
Cross-sectional analyses with multiple linear regression models 
 
To investigate associations between sNfL and GD and T2LV at baseline, two separate multiple 
linear models where conducted, with GD and T2LV as dependent variables, respectively. 
Supplementary Table 7 summarizes the results from linear models testing for 
associations between GD and T2LV with sNfL levels, different treatments and MS phenotypes 
at baseline. Briefly, the model revealed significant associations between sNfL and GD (t(286) 
= 4.62, p < .001), age (t(286) = 3.90, p < .001), and diagnosis (t(286) = 3.94, p < .001), indicating 
higher level of dysconnectivity with higher NfL, higher age and with PMS compared to CIS 
subtype. Significant effects were also evident for both DMT groups compared to no treatment, 
with effective treatment (t(286) = 3.29, p = .001) and highly-effective treatment (t(286) = 4.75, 
p < .001) being associated with higher levels of brain dysconnectivity. The T2LV models 
revealed a significant association with sNfL (t(286) = 2.89, p = .004). In addition, the use of 
any DMTs compared to no treatment was associated with larger lesions, for both effective 
treatment (t(286) = 2.71, p = .007), as well as highly-effective treatment (t(286) = 3.49, p = 
.001). 
 
Supplementary Table 7 Linear regression for global disconnectome and lesion volume at 
baseline with sNfL 
  GD T2LV 
Predictors Estimates CI t p Estimates CI t p 
(Intercept) -1.16 -1.77 – -0.55 -3.70 2.6x10-4 -0.70 -0.83 – -0.56 -10.29 1.5x10-21 
sNfL 0.14 0.08 – 0.21 4.62 5.7x10-6 0.05 0.02 – 0.09 2.89 0.004 
Age 0.24 0.12 – 0.36 3.90 1.2x10-4 0.08 -0.01 – 0.17 1.68 0.094 
Sex [Female] 0.13 -0.08 – 0.34 1.19 0.234 0.03 -0.08 – 0.14 0.54 0.592 
Diagnosis [PMS] 1.39 0.70 – 2.09 3.94 1.0x10-4 0.37 -0.00 – 0.74 1.95 0.052 
Diagnosis [RRMS] 0.52 -0.11 – 1.15 1.63 0.104 0.11 -0.03 – 0.26 1.56 0.121 
Treatment [Effective] 0.44 0.18 – 0.70 3.29 0.001 0.17 0.05 – 0.29 2.71 0.007 
Treatment 
[Highly-effective] 
0.73 0.43 – 1.04 4.75 3.3x10-6 0.35 0.15 – 0.55 3.49 0.001 
Observations 294 294 







Supplementary Figure 1 Visualization of the correlation between global disconnectome 


















Correlation between global disconnectome and lesion volume (r=0.80)
 
 
Supplementary Figure 2 Scatter plot visualizing the distributions of sNfL levels across 
the complete sample with age on the x-axis. 
 
Supplementary Figure 3 Scatter plot visualizing the distributions of sNfL levels across 





Supplementary Figure 4 Visualization of fixed effects coefficients in linear mixed 
models. (A) Higher GD was associated with higher NfL levels, higher age, and PMS 
diagnosis. (B) T2LV was found to increase over time and was associated with higher age. * p 
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